Keflex Articles

Four drugmakers to pay $124 million for submission of false claims to USA’s Medicaid

20 October 2009

Targanta presents more oritavancin data at ICAAC

10 November 2008

Vietnam to resist drug price hike calls

2 June 2008

US retail chain drops discount drug plan in favor of free antibiotics

20 August 2007

Indian Pharma cuts 886 drug prices

13 November 2006

Positive pivotal Phase III results for Vicuron's dalbavancin; NDA filing on track

23 August 2004

US biotech sector tumbles in July as investors react to choppy market conditions

23 August 2004

Advancis buys Lilly's Keflex brand for $11M

5 July 2004

Indian firms win US approvals, other news

6 October 2003

New pivotal data for InterMune's oritavancin

22 September 2003

Australia-US trade deal: Rx price warning

11 August 2003

Glaxo & Ranbaxy to expand abroad?

12 May 1999

Ranbaxy drug trial

17 March 1999

Max-GB Establishes Penicillin Plant

1 October 1998

Lupin Set To Make Acquisition In USA

3 June 1998

Indian Drug Prices Discussed In Parliament

12 August 1997

US Quarterly Results Show Improvements

4 November 1996

Eli Lilly Investing In Brazil

23 September 1996

Israel's Teva Bidding For World Generics Leadership

12 February 1996

Warner-Lambert's cefdinir: new findings

2 October 1995

Eli Lilly Opens Manufacturing Plant

6 March 1995

$25 Bill Latin American Pharma Market In 2000

9 January 1995

LILLY RECALLS ANTIBIOTICS

11 April 1994

NORTON ADDS NEW PRODUCTS IN UK

21 March 1994

BARR LABS REINTRODUCES THREE PRODUCTS

27 September 1993

BARR LABS HAS 24 PRODUCTS SUSPENDED

15 February 1993

BIOCRAFT BOOSTED BY APPROVALS

13 April 1992

BIOCRAFT SETS SIGHTS ON GENERIC CECLOR

17 February 1992

Showing 1-28 of 28 articles

Go to beginningPrevious
  • 1
NextGo to end